Search Results 331-340 of 8941 for Conduction

1. Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study - Mayo Clinic

   ... conduction abnormality not controlled by adequate medication -Angina pectoris requiring anti-angina medication -Clinically significant valvular heart ...

2. Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery - Mayo Clinic

   Prior 2nd or 3rd degree heart block or other types of clinically significant conduction delay ≤6 months prior to registration;; Clinically significant ...

3. Patellofemoral pain syndrome - Doctors and departments - Mayo Clinic

   Rochester, MN. Areas of focus: Electromyography, Amputation rehabilitation, Arthritis rehabilitation, Nerve block, Nerve conduction study, Ultrasound-...

4. A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin amyloidosis - Mayo Clinic

   Current treatment with calcium channel blockers with conduction system effects (e.g., verapamil, diltiazem). The use of dihydropyridine calcium channel ...

5. A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures - Mayo Clinic

   Patients with myocardial compromise or cardiac conduction defects because of magnesium's anti-inotropic effects. Patients with renal insufficiency ...

6. The LEADLESS II IDE Study (Phase II): A Safety and Effectiveness Trial for a Leadless Pacemaker System - Mayo Clinic

   Participation eligibility · Subject has known pacemaker syndrome, has retrograde VA conduction, or suffers a drop in arterial blood pressure with the onset of ...

7. Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid - Mayo Clinic

   Evidence of any of the following cardiac conduction abnormalities during the screening period: A QTc Fredericia interval >450 milliseconds for males and ...

8. A Study to Evaluate the Effectiveness and Safety of G10 in Subjects with Transthyretin Amyloid Cardiomyopathy - Mayo Clinic

   Requires treatment with calcium channel blockers with conduction system effects (e.g., verapamil, diltiazem). The use of dihydropyridine calcium channel ...

9. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   Has a history of cardiac conduction abnormalities including: QTcF >470 msec;; ECG with second degree type 2 or third degree atrioventricular block, and left ...

10. Study to Evaluate the Safety, Tolerability and Preliminary Antitumor Activity of INCB059872 in Patients with Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

    For participants with an intraventricular conduction delay (QRS interval ≥ 120 ms), the JTc interval may be used in place of the QTc with sponsor approval.